trending Market Intelligence /marketintelligence/en/news-insights/trending/b3bzr1squmqihutg5ac1pw2 content esgSubNav
In This List

Novo Nordisk adds board members

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


Novo Nordisk adds board members

Bagsvaerd, Denmark-based Novo Nordisk A/S' board of directors proposed the election of Andreas Fibig and Martin Mackay as board members.

Fibig is the CEO and chairman of International Flavors & Fragrances Inc., while Mackay was formerly the executive vice president and global head of research and development at Alexion Pharmaceuticals Inc.

Both appointments will be proposed at the drugmaker's annual meeting in March.